Begin typing your search...

Zydus Cadila gets USFDA nod for cancer and high blood pressure, treatment drug

2021-04-08 09:23:31

Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Ibrutinib Capsules in the strengths of 70 mg and 140 mg, Cadila Healthcare said in a regulatory filing.

BSE Sensex NSE Nifty Nifty50 
Next Story
Share it